Ladenburg Thalmann Financial Services’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $89K | Buy |
1,968
+233
| +13% | +$10.5K | ﹤0.01% | 3115 |
|
|
2019
Q3 | $66K | Sell |
1,735
-1
| -0.1% | -$38 | ﹤0.01% | 3236 |
|
|
2019
Q2 | $76K | Sell |
1,736
-221
| -11% | -$9.68K | ﹤0.01% | 3171 |
|
|
2019
Q1 | $74K | Sell |
1,957
-17
| -0.9% | -$643 | ﹤0.01% | 3113 |
|
|
2018
Q4 | $85K | Sell |
1,974
-81
| -4% | -$3.49K | ﹤0.01% | 2863 |
|
|
2018
Q3 | $101K | Buy |
2,055
+336
| +20% | +$16.5K | ﹤0.01% | 2808 |
|
|
2018
Q2 | $54K | Hold |
1,719
| – | – | ﹤0.01% | 3203 |
|
|
2018
Q1 | $54K | Hold |
1,719
| – | – | ﹤0.01% | 3203 |
|
|
2017
Q4 | $78K | Sell |
1,719
-893
| -34% | -$40.5K | ﹤0.01% | 2899 |
|
|
2017
Q3 | $98K | Sell |
2,612
-1,491
| -36% | -$55.9K | ﹤0.01% | 2617 |
|
|
2017
Q2 | $196K | Sell |
4,103
-86
| -2% | -$4.11K | ﹤0.01% | 2037 |
|
|
2017
Q1 | $190K | Buy |
4,189
+2,212
| +112% | +$100K | ﹤0.01% | 1952 |
|
|
2016
Q4 | $66K | Buy |
1,977
+45
| +2% | +$1.5K | ﹤0.01% | 2643 |
|
|
2016
Q3 | $67K | Buy |
1,932
+374
| +24% | +$13K | ﹤0.01% | 2556 |
|
|
2016
Q2 | $52K | Sell |
1,558
-1,335
| -46% | -$44.6K | ﹤0.01% | 2644 |
|
|
2016
Q1 | $153K | Sell |
2,893
-535
| -16% | -$28.3K | ﹤0.01% | 1788 |
|
|
2015
Q4 | $264K | Buy |
3,428
+763
| +29% | +$58.8K | ﹤0.01% | 1397 |
|
|
2015
Q3 | $109K | Buy |
2,665
+118
| +5% | +$4.83K | ﹤0.01% | 1917 |
|
|
2015
Q2 | $180K | Buy |
2,547
+23
| +0.9% | +$1.63K | ﹤0.01% | 1681 |
|
|
2015
Q1 | $224K | Buy |
2,524
+804
| +47% | +$71.4K | ﹤0.01% | 1502 |
|
|
2014
Q4 | $152K | Buy |
1,720
+170
| +11% | +$15K | ﹤0.01% | 1620 |
|
|
2014
Q3 | $150K | Buy |
1,550
+100
| +7% | +$9.68K | ﹤0.01% | 1366 |
|
|
2014
Q2 | $133K | Hold |
1,450
| – | – | ﹤0.01% | 1424 |
|
|
2014
Q1 | $101K | Buy |
1,450
+1,400
| +2,800% | +$97.5K | ﹤0.01% | 1499 |
|
|
2013
Q4 | $3K | Hold |
50
| – | – | ﹤0.01% | 3422 |
|
|
2013
Q3 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 3465 |
|